Skip to Content

Repatha Pushtronex (evolocumab) Drug Interactions

There are no known drug interactions for Repatha Pushtronex (evolocumab) - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Repatha Pushtronex (evolocumab) is in the drug class PCSK9 inhibitors. Repatha Pushtronex (evolocumab) is used to treat the following conditions: Cardiovascular Risk Reduction, High Cholesterol, High Cholesterol, Familial Heterozygous, High Cholesterol, Familial Homozygous.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide